INVESTORS

PRESS RELEASES

11 November, 2019
Angion Presents Data on the Impact and Burden of Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
07 November, 2019
Angion Presents Positive Long-term Data from Phase 2 Clinical Trial of ANG-3777 in Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
05 November, 2019
Angion Expands Executive Team to Support the Ongoing and Future Clinical Development of ANG-3777
23 October, 2019
Angion Announces Several Strategic Additions to its Management Team to Support the Future Development and Commercialization of ANG-3777
14 October, 2019
Angion to Present Late-Breaking Data on ANG-3777 in Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
19 April, 2019
Angion Awarded $4.76 Million Department of Defense Grant for Chronic Kidney Disease Drug Candidate ANG-3070
27 January, 2019
Angion Completes Equity Financing and Appoints Senior Executives
02 November, 2018
Angion Biomedica to present at Piper Jaffray Healthcare Conference
01 November, 2018
Angion Biomedica and Sinovant Sciences Enter into Collaboration and License Agreement to Develop BB3 in Greater China
01 September, 2017
Angion Biomedica expands staff with new Director of Chemistry and Director of Clinical Operations
01 June, 2017
Angion Biomedica Corp. in-licenses aldosterone synthase inhibitors from ElexoPharm GmbH, complementing its ongoing program in chronic kidney Disease
01 January, 2017
Angion Biomedica Corp.’s Phase 2 GUARD Clinical Trial of BB3 in Acute Kidney Injury (AKI) Underway; Complements Ongoing Phase 3 Study in Renal Recipients with Delayed Graft Function
01 November, 2015
Angion Biomedica to Present Clinical and Preclinical Data at the Upcoming American Society of Nephrology Conference in San Diego
01 June, 2015
Angion Biomedica Corp. To Commence Phase 2 Clinical Trial of BB3 in Acute Kidney Injury
01 May, 2015
Angion Biomedica Corp. Advances BB3 into Pivotal Phase 3 Clinical Trial in Renal Transplant Patients with Delayed Graft Function

CORPORATE PRESENTATION